Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D in Early Development: Programming and Later Outcomes: Study Summary

Previous related pageVitamin D in Early Development: Programming and Later Outcomes: Full Evidence ReviewNext related pageVitamin D in Early Development: Programming and Later Outcomes: Full Evidence Review
Study at a glance

What was studied?

Researchers studied vitamin D exposure before birth and later development. Human trials measured growth, bone scans and fractures. Rat and mouse experiments examined changes in pancreatic cells and developing blood and immune cells.

What did the studies find?

Changing supplements raised blood measurements in human trials, but did not consistently improve later outcomes. Some childhood bone scans were favourable; other growth and bone outcomes showed no clear difference. Animal experiments found changes in particular tissues or cell populations.

What does this mean?

A blood change, an animal cell finding and a benefit to a child are different results. An effect measured at one age does not prove that it lasts throughout life.

What are the limits?

We could not obtain the full 2026 MAVIDOS report on small-scale bone structure. Its abstract reports no detected group difference, but we could not fully assess its methods or results. Other limits include selected follow-up groups and differences between animal experiments and people.

Read the full article below ↓

Vitamin D studies before birth do not all ask the same question. Some examine cells or organs in animals. Others measure a child’s growth, bones or later health. This summary compares five independent study programmes. They show why a change during development does not automatically mean a lasting health benefit, and why a blood result cannot replace a measured childhood outcome. For the detailed evidence review, read Vitamin D in Early Development: Programming and Later Outcomes: Full Evidence Review.

What was studied?

Researchers studied maternal vitamin D exposure, later outcomes in children, and developmental changes in rats and mice. Some studies randomly assigned pregnant women to different supplements. Other experiments changed maternal diets or transferred cells between animals. These are different kinds of evidence and cannot be interpreted in the same way.

The main blood measure was often 25-hydroxyvitamin D, also called 25(OH)D. It is a substance used to assess vitamin D status. It differs from vitamin D3 in a supplement and from the active vitamin D hormone. A higher blood result does not directly show that a developing organ works better. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains the blood markers, and Vitamin D Activation describes how vitamin D changes between forms.

A supporting study examined human placentas collected at the end of pregnancy. It showed that the placenta can take up and handle vitamin D substances. This helps explain exposure, but it does not show that a supplement improves a child’s later health. Placental tissue studied outside the body also cannot represent every stage of pregnancy.

What happened in the human trials?

The MDIG trial included 1,300 pregnant women in Bangladesh. The assigned supplements changed vitamin D blood measurements, but the researchers did not detect an improvement in the main outcome of infant length relative to age at one year. All groups also received calcium and other care. The finding concerns that trial’s conditions; it does not mean vitamin D is unnecessary for development. A later published correction did not change the overall conclusion.

The UK MAVIDOS trial compared vitamin D3 with placebo during pregnancy. Its main newborn bone measurement did not clearly improve overall. A later follow-up at about six to seven years found some favourable bone-scan results. However, the follow-up was exploratory and included a selected group of children. Several bone measurements were examined, and results were not identical across all measurements.

A 2026 MAVIDOS report examined the small-scale structure of bone. Its abstract reports no detected difference between the groups. We could not obtain the complete paper and its important supplementary material. We therefore could not fully assess the methods or detailed results. This gap matters when comparing that report with the earlier favourable scans. The abstract should be acknowledged, but it cannot stand in for a complete assessment.

The Danish COPSAC trial followed offspring to age 13. It did not establish an improvement in the bone measurements studied or a reduction in fractures. The estimates were uncertain. Children were not followed into adulthood in that report, so it cannot answer questions about lifelong protection.

These trials do not give one simple result for every age or outcome. A favourable scan at one age is not proof of fewer fractures later. Bone Mineralisation, Turnover and Fractures Measure Different Outcomes explains these differences in bone measurements. A result with no clear difference is also not proof that the two treatments have exactly the same effect in every setting.

What did animal experiments add?

In a rat study, maternal vitamin D deficiency covered pregnancy and breastfeeding. Male offspring later had lower selected insulin measurements and less mass of pancreatic beta cells, which produce insulin. The pancreas contains cells that produce insulin. The study did not show the same effect in every test or in both sexes. It also did not establish the proposed change in DNA regulation as the explanation. These results do not show that supplementation prevents diabetes in children.

A mouse experiment examined developing blood and immune-cell populations. Problems handling glucose and responding to insulin persisted after cells were transferred into adult mice receiving vitamin D. This supports further research into how early exposure may affect cells. But transplantation is an artificial setting, and the transferred samples contained different mixtures of cells. A small human cord-blood component was not a follow-up of children’s health.

What does this mean?

Early exposure can affect particular developmental processes in experiments. Human trials also show that supplements can change blood measurements. Neither fact guarantees a lasting health benefit. The species, timing, measured outcome and length of follow-up all matter.

This review has limits. The full 2026 MAVIDOS bone-structure report was unavailable, and some other detailed supplementary analyses were not inspected. The review therefore avoids claims that depend on those missing details. It also does not cover every developing organ. The missing information is a reason to limit conclusions, not to hide reported contrary findings.

For current UK advice, see NHS Pregnancy vitamins and supplements. These studies do not establish one personal dose or blood target.

Sources

Related reading

Original sources

Source

Pregnancy vitamins and supplements

For current UK advice, see NHS Pregnancy vitamins and supplements.

Publication details

For current UK advice, see NHS Pregnancy vitamins and supplements. These studies do not establish one personal dose or blood target.

Read more →
Source

Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth

Published in Roth et al. New England Journal of Medicine (2018).

Publication details

Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Roth et al. New England Journal of Medicine. 2018;379:535 to 546. DOI:10.1056/NEJMoa1800927. Principal assessed; interpretation incorporates the 2021 correction, DOI:10.1056/NEJMx210014. Archived numerical details may predate the correction.

Read more →
Source

Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial

Published in Cooper et al. Lancet Diabetes & Endocrinology (2016).

Publication details

Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Cooper et al. Lancet Diabetes & Endocrinology. 2016;4:393 to 402. DOI:10.1016/S2213-8587(16)00044-9. Principal and relevant supplementary material assessed.

Read more →
Source

Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial

Published in Moon et al. American Journal of Clinical Nutrition (2024).

Publication details

Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. Moon et al. American Journal of Clinical Nutrition. 2024;120:1134 to 1142. DOI:10.1016/j.ajcnut.2024.09.014. Principal and eight supplementary tables assessed; same MAVIDOS trial.

Read more →
Source

Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial

Published in Maden et al. Bone (2026).

Publication details

Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial. Maden et al. Bone. 2026;207:117843. DOI:10.1016/j.bone.2026.117843. ABSTRACT ONLY: full principal and material supplements unavailable; not counted as fully assessed evidence.

Read more →
Source

Prenatal high-dose vitamin D supplementation and offspring bone mineral content and density at age 13 years: a secondary analysis of a randomised clinical trial

Published in Brustad et al. Lancet Regional Health: Europe (2026).

Publication details

Prenatal high-dose vitamin D supplementation and offspring bone mineral content and density at age 13 years: a secondary analysis of a randomised clinical trial. Brustad et al. Lancet Regional Health: Europe. 2026;71:101870. DOI:10.1016/j.lanepe.2026.101870. Principal, material supplementary tables and relevant protocol history assessed; earlier COPSAC reports are the same trial.

Read more →
Source

Maternal Vitamin D Deficiency Impairs the Development of β Cells in Offspring Rats in a Sex-Dependent Manner

Recent studies have shown that maternal vitamin D deficiency (VDD) causes long-term metabolic changes in offspring.

Publication details

Maternal Vitamin D Deficiency Impairs the Development of β Cells in Offspring Rats in a Sex-Dependent Manner. Schavinski et al. International Journal of Molecular Sciences. 2024;25:4136. DOI:10.3390/ijms25084136. Principal, tables, figure descriptions and diet appendix assessed.

Read more →